Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteers

Biopharmaceutics and Drug Disposition

Volumn 29, Issue 4, 2008, Pages 237-244

  Hong, Xin ^a   Liu, Chang Hui ^a   Huang, Xiao Tao ^a   Huang, Tian Lai ^a   Ye, Shao Mei ^a   Ou, Wei Ping ^a   Wang, Ning Sheng ^a   Mi, Sui Qing ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Artekin; Dihydroartemisinin; LC MS; Malaria; Pharmacokinetics

Indexed keywords

ARTEMETHER; DIHYDROARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHINESE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GENDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; REPEATED DRUG DOSE; SINGLE DRUG DOSE; TABLET; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; ANTIMALARIALS; ARTEMISININS; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; TABLETS;

EID: 44949259144     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.607     Document Type: Article

References (38)

1. Grace JM, Aguilar AJ, Trotman KM, Brewer TG. Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450. Drug Metab Dispos 1998; 26: 313.
2. Naik H, Murry DJ, Kirsch LE, Fleckenstein L. Development and validation of a high-performance liquid chromatography-mass spectroscopy assay for determination of artesunate and dihydroartemisinin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 816: 233-242.
3. Ilett KF, Ethell BT, Maggs JL, et al. Glucuronidation of diliydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos 2002; 30: 1005-1012.
4. Raynes K, Forley M, Tilley L, et al. Novel bisquinoline antimalarials: synthesis, antimalarial activity, and inhibition of haem polymerization. Biochem Pharmacol 1996; 52: 551-559.
5. Vennerstrom JL, Ellis WY, Ager AL, et al. Bisquinolines: 1.N, N-bis (7-chloroquinolin-4-yl) alkanediamines with potential against chloroquine-resistant malaria. Med Chem 1992; 35: 2129-2134.
6. Sunderland B, Passmore P, Boddy M. Meeting on Antimalarial Drug Development, Shanghai, China, 16-17 November 2001. World Health Organization Regional Office for the Western Pacific, Annex 6: Manila, 2002; 41.
7. Batty KT, Davis TME, Thu LTA, Binh TQ, Anh TK, Ilett KF. Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria. J Chromatogr B Biomed Appl 1996; 677: 345-350.
8. Thomas CG, Ward SA, Edwards G. Selective determination, in plasma, of artemether and its major metabolite, dihydroartemisinin, by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 1992; 583: 131-136.
9. Muhia DK, Mberu EK, Watkins WM. Differential extraction of artemether and its metabolite dihydroartemisinin from plasma and determination by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1994; 660: 196-199.
10. Gordi T, Nielsen E, Yu Z, Westerlund D, Ashton M. Direct analysis of artemisinin in plasma and saliva using coupled-column high-performance liquid chromatography with a restricted-access material pre-column. J Chromatogr B Biomed Sci Appl 2000; 742: 155-162.
11. Karbwang J, Na-Bangchang K, Molunto P, Banmairuroi V, Congpuong K. Determination of artemether and its major metabolite, dihydroartemisinin, in plasma using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Sci Appl 1997; 690: 259-265.
12. Navaratnam V, Mordi MN, Mansor SM. Simultaneous determination of artesunic acid and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies. J Chromatogr B Biomed Sci Appl 1997; 692: 157-162.
13. Na-Bangchang K, Congpuong K, Hung LN, Molunto P, Karbwang J. Simple high-performance liquid chromatographic method with electrochemical detection for the simultaneous determination of artesunate and dihydroartemisinin in biological fluids. J Chromatogr B Biomed Sci Appl 1998; 708: 201-207.
14. Sabarinath S, Rajanikanth M, Madhusudanan KP, Gupta RC. A sensitive and selective liquid chromatographic/electrospray ionization tandem mass spectrometric assay for the simultaneous quantification of alpha-, beta-arteether and its metabolite dihydroartemisinin in plasma, useful for pharmacokinetic studies. J Mass Spectrom 2003; 38: 732-742.
15. Souppart C, Gauducheau N, Sandrenan N, Richard F. Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 774: 195-203.
16. Rajanikanth M, Madhusudanan KP, Gupta RC. An HPLC-MS method for simultaneous estimation of alpha, beta-arteether and its metaboiite dihydroartemisinin, in rat plasma for application to pharmacokinetic study. Biomed Chromatogr 2003; 17: 440-446.
17. Naik H, Murry DJ, Kirsch LE, Fleckenstein L. Development and validation of a high-performance liquid chromatography - mass spectroscopy assay for determination of artesunate and dihydroartemisinin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 816: 233-242.
18. Xing J, Yan HX, Wang RL, Zhang LF, Zhang SQ. Liquid chromatography - tandem mass spectrometry assay for the quantitation of beta-dihydroartemisinin in rat plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 852: 202-207.
19. Simpson JA, Agbenyega T, Barnes KI, et al. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med 2006; 3: e444.
20. McGready R, Stepniewska K, Ward SA, et al. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. Eur J Clin Pharmacol 2006; 62: 367-371.
21. Na-Bangchang K, Krudsood S, Silachamroon U, et al. The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers. Southeast Asian J Trop Med Public Health 2004; 35: 575-582.
22. Le Ngoc Hung, Na-Bangchang K, Le Thi Diem Thuy, et al. Pharmacokinetics of a single oral dose of dihydroartemisinin in Vietnamese healthy volunteers. Southeast Asian J Trop Med Public Health 1999; 30: 11-16.
23. Binh TQ, Ilett KF, Batty KT, et al. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol 2001; 51: 541-546.
24. Batty KT, Ilett KF, Edwards G, et al. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes. Br J Clin Pharmacol 1998; 125: 159-167.
25. Maggs JL, Madden S, Bishop LP, O'Neill PM, Park BK. The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide. Drug Metab Dispos 1997; 25: 1200-1204.
26. Ilett KF, Davis TME, Batty KT, et al. Glucuronidation of dihydroartemisinin following administration of artesunate to humans and by human liver microsomes. Proceedings of the 5th International ISSX Meeting, Cairns, Australia. 1998; 105.
27. Deng M, liu HC. Effect of gender on pharmacokinetics. Chin J Clin Pharmacol 2004; 20: 67-71.
28. Heinig R, Sundaresan P, Shah A, Boettcher M. Effect of gender and age on the pharmacokinetics of repinotan. Clin Drug Investig 2005; 25: 125-134.
29. Brennan B, Chiu Y, Berthelon L, Kolis S, Davies B. Effect of age and gender on the pharmacokinetics of R667, a novel agent for the treatment of emphysema, in healthy volunteers. J Pharm Pharm Sci 2007; 10: 9-16.
30. Falcao A, Maia J, Almeida L, Mazur D, Gellert M, Soares-da-Silva P. Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker. Biopharm Drug Dispos 2007; 28: 249-256.
31. Kim KM, Choi BM, Park SW, et al. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion. Anesthesiology 2007; 106: 924-934.
32. Park K, Kim YS, Kwon KI, Park MS, Lee YJ, Kim KH. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults. Clin Ther 2007; 29: 154-162.
33. Zhong DF. Pharmacokinetics. In Biopharmaceutics and Pharmacokinetics, Liang WQ (ed.), vol. 2. Chinese Medical Technology Press: 2003; 154-157.
34. Hassan Alin M, Ashton M, Kihamia CM, Mtey GJB, Björkman A. Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg 1996; 90: 61-65.
35. van Agtmael MA, Cheng-Qi S, Qing JX, Mull R, van Boxtel CJ. Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria. Int J Antimicrob Agents 1999; 12: 151-158.
36. Simonsson US, Jansson B, Hai TN, Huong DX, Tybring G, Ashton M. Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin Pharmacol Ther 2003; 74: 32-43.
37. Gordi T, Xie R, Huong NV, Huong DX, Karlsson MO, Ashton M. A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-Qpass hepatic extraction. Br J Clin Pharmacol 2005; 59: 189-198.
38. Karunajeewa H, Lim C, Hung TY, et al. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br J Clin Pharmacol 2004; 57: 93-99.